-transparent.png){kind=logo}
The antinociceptive effects of synthetic dermorphin and its analogues containing D-Arg in position 2 injected into the lateral cerebroventricle were examined in conscious mice. Intracerebroventricular (i.c.v.) administration of dermorphin and [D-Arg2] dermorphin produced potent and long-lasting antinociceptive activity as assayed by the tail-pressure test. Dermorphin and [D-Arg2] dermorphin were 210 and 52 times more potent than morphine, respectively. The antinociceptive effects produced by these heptapeptides were antagonized by a low dose (0.5 mg kg-1, i.p.) of the opioid antagonist naloxone. The ED50 values for [D-Arg2] dermorphin (1-6), (1-5) and (1-4) were not significantly different from that for [D-Arg2] dermorphin. The potency of the shortest fragment, [D-Arg2] dermorphin (1-2) was found to possess a severely reduced activity, whilst [D-Arg2] dermorphin (1-3) maintained activity and was 10 times more potent than morphine. [D-Arg2] dermorphin analogues showed almost identical effects when tested on the electrically-induced contractions of the guinea-pig isolated ileum. These results led us to conclude that the presence of the N-terminal tripeptide in the structure of [D-Arg2] dermorphin is of crucial importance for the manifestation of the full intrinsic opioid-like antinociceptive activity of [D-Arg2] dermorphin, which is presumably mediated through opioid receptors in the brain.
K Kisara, and
S Sakurada, and
T Sakurada, and
Y Sasaki, and
T Sato, and
K Suzuki, and
H Watanabe
January 1985,
Peptides,
K Kisara, and
S Sakurada, and
T Sakurada, and
Y Sasaki, and
T Sato, and
K Suzuki, and
H Watanabe
April 1996,
Chemical & pharmaceutical bulletin,
K Kisara, and
S Sakurada, and
T Sakurada, and
Y Sasaki, and
T Sato, and
K Suzuki, and
H Watanabe
January 1990,
Biopolymers,
K Kisara, and
S Sakurada, and
T Sakurada, and
Y Sasaki, and
T Sato, and
K Suzuki, and
H Watanabe
June 2002,
Chemical & pharmaceutical bulletin,
K Kisara, and
S Sakurada, and
T Sakurada, and
Y Sasaki, and
T Sato, and
K Suzuki, and
H Watanabe
July 1995,
International journal of peptide and protein research,
K Kisara, and
S Sakurada, and
T Sakurada, and
Y Sasaki, and
T Sato, and
K Suzuki, and
H Watanabe
April 1984,
Neuropharmacology,
K Kisara, and
S Sakurada, and
T Sakurada, and
Y Sasaki, and
T Sato, and
K Suzuki, and
H Watanabe
June 2009,
Journal of neurochemistry,
K Kisara, and
S Sakurada, and
T Sakurada, and
Y Sasaki, and
T Sato, and
K Suzuki, and
H Watanabe
April 1977,
The American journal of medicine,
K Kisara, and
S Sakurada, and
T Sakurada, and
Y Sasaki, and
T Sato, and
K Suzuki, and
H Watanabe
February 1999,
Journal of medicinal chemistry,
K Kisara, and
S Sakurada, and
T Sakurada, and
Y Sasaki, and
T Sato, and
K Suzuki, and
H Watanabe
June 2005,
Journal of peptide science : an official publication of the European Peptide Society,
